PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging.

Biodegradable PEGylated Gd-DTPA l-cystine copolymers, PEG-g-poly(GdDTPA-co-l-cystine), were prepared and tested as a blood pool contrast agent in mice. The biodegradable macromolecular agent was designed to be broken down into smaller Gd complexes by endogenous thiols via the disulfide-thiol exchange reaction to facilitate the clearance of Gd complexes after the contrast-enhanced MRI examination. Gd-DTPA l-cystine copolymers were synthesized by condensation polymerization of l-cystine and DTPA-dianhydride in water followed by chelating with Gd(OAc)(3). MPEG-NH(2) (MW = 2000) was then conjugated to the polymeric backbone in different ratios. The macromolecular contrast agent was readily degraded with the incubation of l-cysteine. It also demonstrated superior contrast enhancement in the heart and blood vessels as compared to a low molecular weight control agent, Gd-(DTPA-BMA). At 1 h postcontrast, the PEGylated macromolecular agent still showed prominent enhancement, while little contrast enhancement was detectable in the blood pool by the control agent. PEG-g-poly(GdDTPA-co-l-cystine) shows promise as an MR blood pool imaging agent.

[1]  A. Luciani,et al.  Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes. , 2004, Radiology.

[2]  D. Parker,et al.  Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI , 2004, Magnetic resonance in medicine.

[3]  E. Nagel,et al.  Cardiac magnetic resonance (CMR) imaging: a noninvasive tool for functional and morphological assessment of coronary artery disease: current clinical applications and potential future concepts. , 2003, Journal of interventional cardiology.

[4]  D. Parker,et al.  Poly(l-glutamic acid) Gd(III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging. , 2003, Bioconjugate chemistry.

[5]  Hisataka Kobayashi,et al.  Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. , 2003, Bioconjugate chemistry.

[6]  A. Laghi,et al.  MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease. , 2003, La Radiologia medica.

[7]  M. Botta,et al.  Optimization of the relaxivity of MRI contrast agents: effect of poly(ethylene glycol) chains on the water-exchange rates of Gd(III) complexes. , 2001, Journal of the American Chemical Society.

[8]  K Togashi,et al.  Positive effects of polyethylene glycol conjugation to generation‐4 polyamidoamine dendrimers as macromolecular MR contrast agents , 2001, Magnetic resonance in medicine.

[9]  R Weissleder,et al.  Size optimization of synthetic graft copolymers for in vivo angiogenesis imaging. , 2001, Bioconjugate chemistry.

[10]  Debiao Li,et al.  Contrast-enhanced MR imaging of coronary arteries: comparison of intra- and extravascular contrast agents in swine. , 2001, Radiology.

[11]  S. M. Deneke.  Thiol-based antioxidants. , 2000, Current topics in cellular regulation.

[12]  T. Desser,et al.  Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties. , 1999, Bioconjugate chemistry.

[13]  L. Helm,et al.  Gadolinium‐based linear polymer with temperature‐independent proton relaxivities: a unique interplay between the water exchange and rotational contributions , 1998 .

[14]  Enzo Terreno,et al.  Lanthanide(III) chelates for NMR biomedical applications , 1998 .

[15]  P. Caliceti,et al.  Improvement of pharmacokinetic, immunological and stability properties of asparaginase by conjugation to linear and branched monomethoxy poly(ethylene glycol) , 1996 .

[16]  A. Lindgren,et al.  Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. , 1995, Clinical chemistry.

[17]  M. Brechbiel,et al.  Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivo. , 1995, Magnetic resonance imaging.

[18]  E. Unger,et al.  Block co-polymeric magnetic resonance contrast agents. , 1994, Investigative radiology.

[19]  R Weissleder,et al.  A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. , 1993, Radiology.

[20]  M. Moseley,et al.  Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. , 1990, Radiology.

[21]  C. Gilon,et al.  Attachment of drugs to polyethylene glycols , 1983 .

[22]  D. Hnatowich,et al.  Labeling of preformed liposomes with Ga-67 and Tc-99m by chelation. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.